Diffuse osteosclerosis led first to an endocrine workup, not a cancer diagnosis
A 50-year-old woman arrived with rapidly progressive dyspnea that culminated in breathlessness at rest, and the initial emergency was cardiovascular rather than oncologic. Transthoracic echocardiography showed a massive pericardial effusion with tamponade physiology, prompting urgent pericardiocentesis and pigtail drainage. Her symptoms improved after drainage, but the biologic story had only begun to unfold. When chest CT was obtained during the workup, it revealed multiple sclerotic vertebral and rib lesions, a pattern that immediately shifted attention toward systemic bone disease.
The laboratory profile looked, at first glance, like a classic high-turnover metabolic bone disorder. Bone-specific alkaline phosphatase was strikingly elevated at 1437 IU/L, while liver tests remained normal, making a hepatobiliary source for the alkaline phosphatase elevation unlikely. Mild hypocalcemia, secondary hyperparathyroidism, and severe vitamin D deficiency were also present. In endocrine practice, that combination often points toward Paget disease of bone or osteomalacia, especially when skeletal imaging shows an abnormal bone phenotype. Here, the radiology pushed in a different direction: diffuse and focal axial sclerosis without deformity, cortical thickening, or bone expansion did not fit Paget disease, and the absence of osteopenia or Looser zones made osteomalacia less convincing.
A single sentence captured the danger in the presentation: the bones looked metabolic, but the marrow was malignant.
Biochemistry suggested turnover, but imaging argued for metastasis
Markedly elevated bone-specific alkaline phosphatase can reflect osteoblastic activity from either benign bone remodeling or tumor-driven osteogenesis. In this case, the biochemical phenotype was reinforced by mild hypocalcemia and elevated parathyroid hormone, which can arise from vitamin D deficiency, but can also accompany increased skeletal calcium uptake in the setting of aggressive bone formation. Severe vitamin D deficiency was documented, with 25-hydroxyvitamin D at 5.9 ng/mL, and that finding would have been easy to overvalue if the radiographic picture had not been scrutinized closely. The axial-predominant distribution of sclerosis, the short symptom duration, and the absence of the structural bone changes expected in Paget disease argued against a purely endocrine process.
Whole-body 18F-FDG PET/CT clarified the diagnostic direction. The scan demonstrated multiple sclerotic skeletal lesions with mild, homogeneous marrow uptake, a pattern that supported metastatic involvement rather than a benign high-turnover bone disorder. Tumor-related osteoblastic metastases can be deceptive because they may generate sclerosis without the aggressive lytic destruction clinicians often associate with cancer in bone. In gastric adenocarcinoma, diffuse osteoblastic spread is exceptionally rare, which is precisely why the diagnosis can be missed when the first clues appear in the endocrine laboratory rather than in the gastrointestinal tract. The biology is plausible: metastatic cells can stimulate osteoblasts and distort normal remodeling, turning bone into a target organ of paraneoplastic mimicry.
The primary lesion was hidden in the stomach, not the skeleton
Upper gastrointestinal endoscopy identified a lesion in the gastric antrum, and biopsy confirmed poorly differentiated signet-ring cell adenocarcinoma. Bone marrow biopsy then established metastatic disease, confirming stage IV cancer with diffuse osteoblastic skeletal metastases. The pericardial fluid was exudative and bloody, with markedly elevated lactate dehydrogenase, but cytology did not reveal malignant cells. Even without cytologic proof from the pericardial space, the tamponade still mattered clinically because it signaled advanced systemic illness and forced the team to search beyond a single organ system.
This pattern is exactly where diagnostic discipline pays off. A patient with dyspnea, effusion, and bone abnormalities can easily be pulled toward separate explanations—cardiac, metabolic, and pulmonary—when the real diagnosis sits underneath all three. The chest CT, bone chemistry profile, PET/CT pattern, and tissue diagnosis aligned only after the team resisted the temptation to stop at the first plausible endocrine explanation. Gastric signet-ring cancers are notorious for late discovery and for metastatic behavior that does not always match the usual template of gastrointestinal malignancy. Bone can be the first site to announce the disease, even when the primary lesion remains silent.
Osteoblastic metastases can masquerade as Paget disease or osteomalacia
The case carries a practical warning for endocrinologists, radiologists, and internists alike. Osteoblastic skeletal metastases can reproduce the biochemical signature of high bone turnover, including a dramatic rise in bone-specific alkaline phosphatase, and they can also generate sclerosis that looks metabolically familiar. Paget disease usually produces characteristic bone enlargement and cortical thickening, while osteomalacia typically brings osteopenia and pseudofractures; neither pattern matched the imaging here. Instead, the distribution and morphology of the lesions fit metastatic infiltration much better than a primary bone remodeling disorder.
The cardiac tamponade added another layer of urgency. Massive pericardial effusion in a patient with unexplained skeletal sclerosis should prompt a broad malignancy search, especially when constitutional symptoms and gastrointestinal complaints have already surfaced. The combination of fluid drainage, CT findings, PET/CT interpretation, and histopathology created the final diagnosis, but the sequence matters because each step corrected a different cognitive bias. Early anchoring on vitamin D deficiency or secondary hyperparathyroidism would have been understandable, yet incomplete. The endocrine abnormalities were real; they were just not the whole story.
For bedside care, the case changes the threshold for thinking about cancer when bone turnover markers look extreme and imaging is atypical. Severe elevation of bone-specific alkaline phosphatase should not be assigned automatically to Paget disease or vitamin D deficiency when the skeleton shows diffuse sclerosis, especially if axial lesions dominate and the clinical course is brief. Tissue diagnosis remains essential when the radiologic pattern and chemistry point in different directions. The central lesson is not that endocrine mimics are rare, but that they can be dangerous precisely because they feel familiar. A malignant process can hide inside a laboratory profile that appears entirely metabolic, and the skeleton may be the first organ to expose it.